| Literature DB >> 26993973 |
H El-Tahry1, Hany E Marei, A Shams1, M El-Shahat2, H Abdelaziz3, M Abd El-Kader1.
Abstract
Demyelination was induced by two weeks cuprizone treatment. Rats of +ve control and triiodothyronine (T3) then received three subcutaneous injections of either saline or T3 day after day and sacrificed at the end of the third and fifth weeks. Animals in -ve control group received only standard rodent chow. After one week of cuprizone withdrawal the corpus callosum in +ve control and T3 treated rats was still demyelinated as revealed by MBP immunohistochemistry. The assay of PLP gene showed significant increase of T3 treated group compared to both the -ve control and +ve control groups. After three weeks, significant improvement in myelination was detected in T3-treated group compared to +ve control as detected by both MBP immunohistochemistry and electron microscopy. After one week of cuprizone withdrawal, PDGFRα positive cells and gene expression showed significant increase in +ve control and T3-treated groups as compared to -ve control with insignificant difference in between the former two groups. After three weeks of cuprizone withdrawal, PDGFRα positive cells in T3-treated and +ve control groups decreased to the control levels. These results suggest that T3 was effective in improving remyelination when administered during acute phase and might direct progenitor lineage toward oligodendrocytes.Entities:
Keywords: Cuprizone; Oligodendrocyte progenitor cells; Remyelination; Triiodothyronine
Mesh:
Substances:
Year: 2016 PMID: 26993973 DOI: 10.1016/j.tice.2016.03.001
Source DB: PubMed Journal: Tissue Cell ISSN: 0040-8166 Impact factor: 2.466